Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mink Therapeutics Inc
(NQ:
INKT
)
0.8200
+0.0123 (+1.52%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mink Therapeutics Inc
< Previous
1
2
3
4
Next >
MiNK Therapeutics Presents Clinical Activity and Long-Term Persistence of Allogeneic iNKT Cells in Solid Tumors at SITC 2023
November 03, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK to Provide Third Quarter 2023 Financial Report and Corporate Update
October 30, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
Sacks Parente Golf And 3 Other Stocks Under $2 Insiders Are Buying
October 17, 2023
The Dow Jones closed higher by more than 300 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Cadrenal Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying
October 09, 2023
The Dow Jones closed higher by around 290 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Latest Analyst Ratings for MiNK Therapeutics
May 12, 2023
Via
Benzinga
Recap: MiNK Therapeutics Q1 Earnings
May 11, 2023
Via
Benzinga
Preview: MiNK Therapeutics's Earnings
March 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 04, 2023
Via
Benzinga
MiNK Therapeutics To Present Data Update From Allogeneic iNKT Cells in Solid Tumors at SITC 2023
September 27, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics to Participate in September Investor Conferences
August 24, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics Reports Second Quarter 2023 Results
August 10, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update
July 28, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
June 22, 2023
Via
Benzinga
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
June 05, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Presents Clinical Data on Allogeneic iNKT Cells (agenT-797) in Severe Respiratory Distress at the American Thoracic Society International Conference
May 22, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK's Novel FAP-CAR-iNKT Presented at ASGCT
May 18, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
Over $1M Bet On This Basic Materials Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
May 15, 2023
The Dow Jones closed slightly lower on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny...
Via
Benzinga
MiNK Therapeutics Reports Corporate Update and First Quarter 2023 Financial Results
May 11, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
First Foundation And 2 Other Penny Stocks Insiders Are Aggressively Buying
May 05, 2023
The Dow Jones closed lower on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 04, 2023
Via
Benzinga
MiNK Therapeutics to Report First Quarter 2023 Corporate Update and Financial Results
April 27, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics Announces Clinical Data of Allogeneic iNKT Cells (agenT-797) in Solid Tumor Cancers at the AACR Annual Meeting
April 18, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
Agenus Announces Dividend of 5 Million Shares of MiNK Therapeutics
March 30, 2023
From
Agenus Inc.
Via
Business Wire
MiNK Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
March 21, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
Earnings Scheduled For March 21, 2023
March 21, 2023
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 17, 2023
Via
Benzinga
MiNK Therapeutics to Present Updated Clinical Data of allo-iNKT Cell Therapy in Solid Tumors at AACR Annual Meeting
March 15, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results
March 07, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics to Participate in HC Wainwright Cell Therapy Virtual Conference
February 16, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics to Participate in B. Riley Securities Oncology Conference
January 11, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.